Theratechnologies Inc. (TH.TO)
-Toronto 0.26 
0.02(7.14%) 2:28PM EDT
| Prev Close: | 0.28 |
|---|
| Open: | 0.26 |
|---|
| Bid: | 0.26 |
|---|
| Ask: | 0.27 |
|---|
| 1y Target Est: | 0.53 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.26 - 0.27 |
|---|
| 52wk Range: | 0.24 - 1.90 |
|---|
| Volume: | 6,863 |
|---|
| Avg Vol (3m): | 53,910 |
|---|
| Market Cap: | 15.86M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Announcements in Conjunction With Theratechnologies Annual MeetingMarketwired(Fri 1:04PM EDT)
- Annonces en marge de l'assemblée annuelle de TheratechnologiesMarketwired(Fri 12:55PM EDT)
- Q1 2013 Thera Technologies Earnings Release - Before Market OpenCCBN(Thu, Apr 11)
- Theratechnologies annonce ses résultats financiers pour le premier trimestre de 2013Marketwired(Thu, Apr 11)
- Theratechnologies Announces Financial Results for First Quarter of 2013Marketwired(Thu, Apr 11)
- RAPPEL : Theratechnologies annoncera ses résultats du premier trimestre de 2013Marketwired(Wed, Apr 10)
- REMINDER: Theratechnologies to Announce First Quarter 2013 Financial ResultsMarketwired(Wed, Apr 10)
- Nomination de l'ancienne présidente de Merck Canada au conseil d'administration de TheratechnologiesMarketwired(Tue, Apr 9)
- Theratechnologies Board of Directors Appoints Former Merck Canada PresidentMarketwired(Tue, Apr 9)
- Theratechnologies annonce la fin de son entente avec FerrerMarketwired(Mon, Apr 8)
- Theratechnologies Announces Termination of Agreement With FerrerMarketwired(Mon, Apr 8)
- Theratechnologies to Announce First Quarter 2013 Financial ResultsMarketwired(Thu, Apr 4)
- Theratechnologies annoncera ses résultats du premier trimestre de 2013Marketwired(Thu, Apr 4)
- Theratechnologies inc. : Une entente sur la renégociation du bail entrainera des économies annuelles importantesMarketwired(Wed, Apr 3)
- Theratechnologies Inc.: Renegotiated Lease to Generate Substantial Annual SavingsMarketwired(Wed, Apr 3)
Key Statistics
| Forward P/E (1 yr): | 26.00 |
|---|
| P/S (ttm): | 1.40 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Nov-13)
: | -0.01 |
|---|
| Quarterly EPS Est
(May-13)
: | -0.01 |
|---|
| Mean Recommendation*: | 3.3 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Theratechnologies Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic peptide products with a focus on growth-hormone releasing factor (GRF) peptides.
View More